Transvaginal Ultrasonography As a Screening Method for Ovarian Cancer

Description

This is a large, prospective, single-arm cohort study of transvaginal ultrasonographic screening for ovarian cancer in intermediate to high-risk women from Kentucky. Detection of ovarian malignancy often occurs subsequent to the initial transvaginal sonography (TVS) screen; therefore, it is important to offer continued screening to study participants based on our published algorithm. Screening will be available to participants for as long as they elect to receive it. The primary study endpoints are to determine if prospective serial transvaginal ultrasonography can decrease the false-positive (FP) percentage and improve the positive predictive value (PPV) as suggested by retrospective analysis without compromising the detection of true positives or promote the occurrence of false negatives.

Conditions

Ovarian Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a large, prospective, single-arm cohort study of transvaginal ultrasonographic screening for ovarian cancer in intermediate to high-risk women from Kentucky. Detection of ovarian malignancy often occurs subsequent to the initial transvaginal sonography (TVS) screen; therefore, it is important to offer continued screening to study participants based on our published algorithm. Screening will be available to participants for as long as they elect to receive it. The primary study endpoints are to determine if prospective serial transvaginal ultrasonography can decrease the false-positive (FP) percentage and improve the positive predictive value (PPV) as suggested by retrospective analysis without compromising the detection of true positives or promote the occurrence of false negatives.

Transvaginal Ultrasonography As a Screening Method for Ovarian Cancer

Transvaginal Ultrasonography As a Screening Method for Ovarian Cancer

Condition
Ovarian Cancer
Intervention / Treatment

-

Contacts and Locations

Lexington

Markey Cancer Center, Lexington, Kentucky, United States, 40536

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * women over the age of 50 years;
  • * women with a documented family history of ovarian cancer over the age of 24 years;
  • * women over the age of 24 years with a personal history of breast cancer
  • * ECOG performance status of 0 to 2.34
  • * Subjects having undergone prior hysterectomy will be eligible provided that they meet the other requirements for entry into this study and have at least one ovary.
  • * Ability to understand and the willingness to sign a written informed consent document.
  • * Women who are referred with pelvic symptoms, a known pelvic mass or a history of prior radiation.
  • * Individuals that cannot safely receive transvaginal ultrasound due to vaginal size, vaginal infections, lack of bowel or bladder control or inability to physically place their body in position to receive transvaginal ultrasound
  • * Prisoners
  • * Pregnant women
  • * Women with a prior history of ovarian cancer
  • * Exclusions will apply to anyone who presents with factors or issues that prevent them from understanding the screening research procedures or completing the informed consent component or personal information needed for the study

Ages Eligible for Study

24 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

John R van Nagell,

John R Van Nagell, MD, PRINCIPAL_INVESTIGATOR, University of Kentucky

Study Record Dates

2026-12-31